WRBY vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

WRBY

35.1
AI Score
VS
XRAY Wins

XRAY

47.9
AI Score

Investment Advisor Scores

WRBY

35score
Recommendation
AVOID NEW MONEY

XRAY

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric WRBY XRAY Winner
Forward P/E 45.045 7.2359 XRAY
PEG Ratio 0 0.7238 Tie
Revenue Growth 10.4% -4.1% WRBY
Earnings Growth -16.3% 15.2% XRAY
Tradestie Score 35.1/100 47.9/100 XRAY
Profit Margin 0.8% -15.0% WRBY
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD XRAY

Relative Price Performance (Last 90 Days)

WRBY 1M: +13.7% · 3M: +16.5% XRAY 1M: +14.8% · 3M: -15.7%

Current Technical Phase

WRBY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.0 · Price: $30.15

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

Fundamentals Snapshot

Metric WRBY XRAY
Market Cap — —
Forward P/E 47.5 7.8
Trailing P/E 498.3 —
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.0% 0.0%
EPS 0.06 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.